{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:12:16Z","timestamp":1790500336898,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[1999,7,1]],"date-time":"1999-07-01T00:00:00Z","timestamp":930787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[1999,7]]},"DOI":"10.4065\/74.7.730","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T20:16:10Z","timestamp":1232741770000},"page":"730-734","source":"Crossref","is-referenced-by-count":152,"title":["Trimethoprim-Sulfamethoxazole"],"prefix":"10.4065","volume":"74","author":[{"given":"Jerry D.","family":"Smilack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/74.7.730_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7326\/0003-4819-91-3-420","article-title":"Trimethoprim-sulfamethoxazole in the United States","volume":"91","author":"Wormser","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.7.730_bib2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1056\/NEJM197409192911209","article-title":"Combinations of antimicrobial drugs: trimethoprimsulfametlioxazole [editorial)","volume":"291","author":"Finland","year":"1974","journal-title":"H Engl J Med"},{"issue":"Suppl","key":"10.4065\/74.7.730_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/128.Supplement_3.S437","article-title":"Mechanism of action of trimethoprim-sulfamethoxazole. II","volume":"128","author":"Burchall","year":"1973","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.4065\/74.7.730_bib4","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1093\/clinids\/24.Supplement_1.S63","article-title":"Increases in rates of resistance to trimethoprim","volume":"24","author":"Huovlnen","year":"1997","journal-title":"Clin tnlecl Dis"},{"key":"10.4065\/74.7.730_bib5","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.281.8.736","article-title":"Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women","volume":"281","author":"Gupta","year":"1999","journal-title":"JAMA"},{"key":"10.4065\/74.7.730_bib6","series-title":"physicians' Desk Reference","first-page":"2438","author":"Bactrim","year":"1998"},{"issue":"RR-12","key":"10.4065\/74.7.730_bib7","first-page":"l","article-title":"1997 USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus","volume":"46","author":"Canters for Disease Control and Prevention","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.4065\/74.7.730_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocysts carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/74.7.730_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4065\/71.1.102","article-title":"Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: who should receive prophylaxis?","volume":"71","author":"Sepkowltz","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/74.7.730_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0891-5520(20)30695-4","article-title":"Vancomycin, trimethoprim-sulfamethoxazole, and rifampin","volume":"9","author":"Lundstrom","year":"1995","journal-title":"Infect Dis Clin North Am"},{"key":"10.4065\/74.7.730_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","article-title":"Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis","volume":"335","author":"Stegeman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.4065\/74.7.730_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJM199607043350113","article-title":"Empiricism and Wegener's granulomatosis [editorial]","volume":"335","author":"DeRemee","year":"1996","journal-title":"N Engl J Med"},{"key":"10.4065\/74.7.730_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.qjmed.a030133","article-title":"Response to trimethoprim\/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease","volume":"89","author":"Relnhold-Keller","year":"1996","journal-title":"QJM"},{"key":"10.4065\/74.7.730_bib14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/ndt\/12.4.652","article-title":"Cotrimoxazole and Wegener's granulomatosis: more than a coincidence? [editorial]","volume":"12","author":"Stegeman","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.4065\/74.7.730_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.7326\/0003-4819-122-8-199504150-00007","article-title":"Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritoni tis in cirrhosis: a randomized trial","volume":"122","author":"Singh","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.7.730_bib16","first-page":"891903","article-title":"Nocardiosis","volume":"22","author":"Lemer","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.7.730_bib17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/513764","article-title":"1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever","volume":"25","author":"Hughes","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.7.730_bib18","first-page":"83","article-title":"Advantages and disadvantages of antimicrobial prophylaxis in chronic granulomatous disease of childhood","volume":"7","author":"Gonzales","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/74.7.730_bib19","first-page":"881890","article-title":"Trimethoprim-sulfamethoxazole for bacterial meningitis","volume":"100","author":"Lavlti","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.7.730_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/24.1.1","article-title":"Listeriosis","volume":"24","author":"Lorber","year":"1997","journal-title":"Clin lnfect Dis"},{"key":"10.4065\/74.7.730_bib21","first-page":"132","article-title":"Management of urinary tract infections in adults","volume":"329","author":"Stamm","year":"1993","journal-title":"N Engl J Med"},{"key":"10.4065\/74.7.730_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jama.1995.03520250057034","article-title":"Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women","volume":"273","author":"Hooton","year":"1995","journal-title":"JAMA"},{"key":"10.4065\/74.7.730_bib23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-124-4-199602150-00008","article-title":"Understanding intestinal spore-forming protozoa: cryptosporidia, microsporidia, isospora, and cyclospora","volume":"124","author":"Goodgame","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.7.730_bib24","series-title":"Drug Prescribing in Renal Failure: Dosing Guidelines for Adults","author":"Aronoff","year":"1999"},{"key":"10.4065\/74.7.730_bib25","series-title":"The Medical Management of AIDS","first-page":"125","article-title":"Drug interactions and toxicities in patients with AIDS","author":"Lee","year":"1997"},{"key":"10.4065\/74.7.730_bib26","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/clinids\/24.5.936","article-title":"Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis","volume":"24","author":"Veenstra","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.7.730_bib27","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1086\/516993","article-title":"Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus","volume":"25","author":"Smith","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.7.730_bib28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/clinids\/20.4.849","article-title":"Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ","volume":"20","author":"Gluckstein","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4065\/74.7.730_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00002030-199506000-00007","article-title":"Two-day oral desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients","volume":"9","author":"Nguyen","year":"1995","journal-title":"AIDS"},{"key":"10.4065\/74.7.730_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/106002809603000214","article-title":"Trimethoprim\/sulfamethoxazole desensitization","volume":"30","author":"Cortese","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.4065\/74.7.730_bib31","first-page":"35","article-title":"Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection","volume":"76","author":"Beclhi-Hentandez","year":"1996","journal-title":"Ann Allergy Astfima Immunol"},{"key":"10.4065\/74.7.730_bib32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00006454-199605000-00015","article-title":"Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children","volume":"15","author":"Palusci","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.4065\/74.7.730_bib33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.1997.03890400065009","article-title":"Efficacy and safety of desensitization with sulfamethoxazole and tri-methoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus","volume":"133","author":"Caumes","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.4065\/74.7.730_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.7326\/0003-4819-119-4-199308150-00007","article-title":"Trimethoprim-sulfamethoxazole induces reversible hyperkalemia","volume":"119","author":"Greenberg","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.7.730_bib35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.7326\/0003-4819-124-3-199602010-00006","article-title":"Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole","volume":"124","author":"Alappan","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.7.730_bib36","first-page":"187","article-title":"Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose","volume":"46","author":"Perazella","year":"1996","journal-title":"Clin Nephrol"},{"key":"10.4065\/74.7.730_bib37","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0272-6386(97)90473-X","article-title":"Hyperkalemia and trimethoprim-sulfamethoxazole","volume":"29","author":"Ellison","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.4065\/74.7.730_bib38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-119-4-199308150-00008","article-title":"Renal mechanism of trimethoprim induced hyperkalemia","volume":"119","author":"Velazquez","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.7.730_bib39","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1128\/AAC.41.11.2466","article-title":"Effects of moderate dose versus high-dose trimethoprim on serum creatinine and creatinine clearance and adverse reactions","volume":"41","author":"Naderer","year":"1997","journal-title":"Antimicrob Agents Chem other"},{"key":"10.4065\/74.7.730_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/adc.73.3.257","article-title":"Co-trimoxazole induced aseptic meningitis","volume":"73","author":"Pashankar","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.4065\/74.7.730_bib41","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.46.2.556","article-title":"Trimethoprim and Sulfonamide-associated meningoencephalitis with MRI correlates","volume":"46","author":"Blumenleld","year":"1996","journal-title":"Neurology"},{"key":"10.4065\/74.7.730_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00000441-199607000-00005","article-title":"Case reports: trimethoprim-sulfamethoxazole-induced meningitis in patients with HIV infection","volume":"312","author":"Jurado","year":"1996","journal-title":"Am J Med Sei"},{"key":"10.4065\/74.7.730_bib43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-9343(98)00408-2","article-title":"Drug interactions and anti-infective therapies","volume":"106","author":"Gregg","year":"1999","journal-title":"Am J Med"},{"key":"10.4065\/74.7.730_bib44","first-page":"6","article-title":"Revised indications for co-trimoxazole (Septrin, Bactrim, various generic preparations)","volume":"21","author":"Committee on the Safety of Medicines\/Medicines Control Agency","year":"1995","journal-title":"Curr Probl Pharmacovigil"},{"key":"10.4065\/74.7.730_bib45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/dtb.1995.331292","volume":"33","author":"Co-trimoxazole use restricted","year":"1995","journal-title":"Drug Ther Bull"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611650763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611650763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T09:52:10Z","timestamp":1632995530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611650763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1999,7]]}},"alternative-id":["S0025619611650763"],"URL":"https:\/\/doi.org\/10.4065\/74.7.730","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[1999,7]]}}}